Mechanistically, Abraxane® leverages albumin’s interaction with gp60 and SPARC receptors to facilitate receptor-mediated transcytosis, enhance tumor accumulation, and increase intracellular drug delivery [32–34]. This evidence concerns the gene ALB and neoplasm.